|
1.
|
Clear description of the referenced document:
|
|
|
|
Name:
|
IHE PCD-TF-2 (2011)
|
|
Title:
|
IHE Patient Care Device (PCD) Technical Framework, Volume 2 (PCD TF-2): Transactions, Revision 1.0
|
|
|
2.
|
Status of approval:
|
|
|
Final text specification approved 2011-08-12.
|
|
3.
|
Justification for the specific reference:
|
|
|
The Continua Design Guidelines uses/generates the IHE Technical Framework for use with both its Health Reporting Network (HRN) and Wide Area Network (WAN) interfaces. This document, the IHE Patient Care Device Technical Framework (IHE PCD TF), defines specific implementations of established standards to achieve integration goals for the Patient Care Device domain. Such integration promotes appropriate sharing of medical information to support optimal patient care.
|
|
4.
|
Current information, if any, about IPR issues:
|
|
|
N/A.
|
|
5.
|
Other useful information describing the "Quality" of the document:
|
|
|
Specification approved 12 August 2011, and there are several certified devices implementing this version of the specification exist.
|
|
6.
|
The degree of stability or maturity of the document:
|
|
|
Specification approved 12 August 2011, and there are several certified devices implementing this version of the specification exist. This document is an integral part of the IHE message data payload and explains how transactions are executed.
|
|
7.
|
Relationship with other existing or emerging documents:
|
|
|
At its current level of development, it defines a coordinated set of transactions based on ASTM, DICOM, HL7, IEEE, IETF, ISO, OASIS and W3C standards.
|
|
8.
|
Any explicit references within that referenced document should also be listed:
|
|
|
HL7 - Health Level 7 Version 2.6 Chapter 7 Observation Reporting/
/
ISO/IEEE 11073-10201 Domain Information Model 335/
/
ISO/IEEE 11073-10101 Nomenclature
|
|
9.
|
Qualification of
IHE:
|
|
|
Integrating the Healthcare Enterprise (IHE) meets the qualifying criteria for normative referencing as per Recommendation ITU-T A.5.
|
|
10.
|
Other (for any supplementary information):
|
|
|
N/A.
|
